Precision botanical contract solutions structured to transform preclinical active phytochemicals into market-ready finished drugs, supplements, and bio-functional ingredients.
Global biopharmaceutical and consumer wellness industries are shifting fundamentally from low-cost assembly towards evidence-led, digitally synchronized CDMO ecosystems.
Regulatory agencies worldwide—including the US FDA, European EFSA, and China's NMPA—demand strict analytical fingerprinting and molecular-level quantification. Generic "herbal powders" have yielded to standardized phytochemical isolates with verifiable preclinical toxicology, in-vitro target validation, and documented bio-equivalence profiles.
The standard OEM paradigm has fragmented into isolated supply chains. The emerging global standard requires an integrated CRO/CDMO architecture capable of taking native botanical specimens from wild-craft geo-authentication directly through animal pharmacokinetics (PK/PD) and into high-capacity commercial dosage machinery.
International buyers require chemistry, manufacturing, and control (CMC) dossiers that seamlessly withstand scrutiny across cross-border markets. Leading Chinese manufacturers now structure HPLC, HPTLC, and GC chromatographic packages to satisfy United States Pharmacopeia (USP) and European Pharmacopoeia (Ph. Eur.) monographs directly.
How Chinese biomanufacturing plants leverage intelligent sensors, continuous micro-countercurrent extraction, and closed-loop data architecture to establish global cost and quality resilience.
Real-time spectral inline sensors govern critical control parameters (CCPs) including solvent ratios, temperature profiles, column separation kinetics, and vacuum concentration. Variations are stabilized automatically in milliseconds, eliminating manual human batch error.
China's unmatched ecological diversity gives industrial processors immediate access to regional GAP-certified agrarian hubs (Daodi herbal origins). By sampling actively across multiple growth zones and temporal seasons, our operations smooth seasonal active ingredient fluctuations into homogenous industrial outputs.
Through super-critical carbon dioxide extraction, macroporous adsorption resin columns, and industrial continuous freeze-drying towers, production throughput yields up to 40% higher recovery rates of fragile polysaccharides and polyphenols while drastically lowering raw solvent and operational energy expenditures.
Over 14+ years of dedicated contract botanical research, MedGence has supported state-level pharmaceutical groups, premier academic institutions, and multinational brands.
From single-compound target screening to phase clinical trial validations and final consumer delivery dosage forms, every tier is backed by enforceable documentation.
| Development Stage | Core Analytical & Technical Scope | Key Instrumentation Used | Final Tangible Buyer Deliverable |
|---|---|---|---|
| Phase 01: Botanical Screening | Target compound identification, seasonal variation testing, ecological harvesting origin comparisons | UPLC-Q-TOF-MS, HPLC-DAD, Botanical Herbarium Records | Comprehensive Botanical Origin & Phytochemical Potency Study Report |
| Phase 02: Analytical Standard | Method development, chromatographic fingerprinting, chemical marker qualitative identification | High-Performance Thin-Layer Chromatography (HPTLC), HPLC, GC | Validated Pharmacopeial-Grade Analytical Method Dossier & QC Protocol |
| Phase 03: Process Engineering | Pretreatment parameters, temperature profiles, resin extraction & spray/freeze drying scale-up | Pilot Countercurrent Extractors, Continuous Membrane Separation Units | Optimized Engineering SOPs & Industrial Yield Maximization Blueprint |
| Phase 04: Preclinical Biology | Cytotoxicity assays, cell line bioactivity validation, LD50 acute/chronic toxicity, Ames genotoxicity | Microplate Reader, Flow Cytometry, SPF In Vivo Laboratory Facilities | GLP-Compliant Safety Pharmacology & In Vitro/In Vivo Research Dossier |
| Phase 05: Clinical Trials | Small-scale human proof-of-concept, Phase I through Phase IV trials for New Drug Application (NDA) | Multi-Center GCP Hospital Network Collaboration Systems | Statistically Validated Clinical Evidence & Efficacy Submission Report |
| Phase 06: Commercial CDMO | Finished oral dosage mass manufacture: oral liquids, softgels, hard capsules, functional tablets, powders | High-Speed Encapsulators, Rotary Tablet Presses, Automatic Blister Lines | Finished Commercial Inventory with Strict IP Non-Disclosure Execution |
How pharmaceutical enterprises, clinical research organizations, nutraceutical innovators, and bio-cosmetic brands leverage our infrastructure.
Providing standardized botanical extract powders, water-soluble microencapsulated formulations, and bio-enhanced herbal compounds. Designed to support structure-function claims on modern retail shelves and high-velocity digital health marketplaces.
Targeting high-affinity botanical fractions for oncology, metabolic disorders, and neuro-protection pipelines. We deliver comprehensive NDA-enabling preclinical dossiers covering pharmacodynamics, GLP-compliant toxicological safety, and human Phase I-IV design.
Natural antioxidant, anti-inflammatory, and brightening active principles derived from pure botanical tissues. Tested via in-vitro transdermal absorption profiling and skin-cell viability assays to ensure irritancy-free, clean-label formulation excellence.
Our validated scientific standards and manufacturing capabilities are relied upon by national pharmaceutical conglomerates and tier-one university medical centers.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtze River Pharma
Gofar Bio
Humanwell Group
SCIMYTH Pharma
Hanfang Pharma
Luoxin Pharma
Zhongsheng Pharma
Apeloa Pharma
Heng Chang Pharma
Baotou TCM
Santo Pharma
Shuguang HospitalStraightforward answers addressing intellectual property, quality validation, minimum order criteria, and clinical trial architectures.
Directly engage our contract research units and high-capacity manufacturing suites for your custom phytochemical program.